Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-05

Clinical Trial Update: Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the accuracy of Indocyanine Green fluorescence imaging during surgery for Tenosynovial Giant Cell Tumor; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital | Conditions: Tenosynovial Giant Cell Tumor | Phase 4 | Status: RECRUITING